OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
8,000.00
-80.00 (-0.99%)
At close: Feb 13, 2026
21.40% (1Y)
| Market Cap | 141.17B +35.5% |
| Revenue (ttm) | 87.58B +11.1% |
| Net Income | 11.18B +17.6% |
| EPS | 731.00 +17.4% |
| Shares Out | 17.65M |
| PE Ratio | 10.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 114,853 |
| Average Volume | 179,353 |
| Open | 8,080.00 |
| Previous Close | 8,080.00 |
| Day's Range | 7,890.00 - 8,200.00 |
| 52-Week Range | 5,610.00 - 8,960.00 |
| Beta | 0.47 |
| RSI | 58.30 |
| Earnings Date | Jan 23, 2026 |